NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 26 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $303,000 | -18.8% | 125,962 | -1.5% | 0.00% | – |
| Q1 2017 | $373,000 | +30.9% | 127,925 | +0.2% | 0.00% | – |
| Q4 2016 | $285,000 | -72.5% | 127,661 | +0.1% | 0.00% | -100.0% |
| Q3 2016 | $1,036,000 | +577.1% | 127,485 | +281.0% | 0.00% | – |
| Q2 2016 | $153,000 | +10.1% | 33,457 | -0.3% | 0.00% | – |
| Q1 2016 | $139,000 | -46.5% | 33,567 | -0.1% | 0.00% | – |
| Q4 2015 | $260,000 | -6.1% | 33,611 | +57.1% | 0.00% | – |
| Q3 2015 | $277,000 | – | 21,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|